Development
Lantern Pharma Inc.
LTRN
$4.99
-$0.15-2.92%
NASDAQ
09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -6.31% | -6.97% | -6.62% | -4.55% | -6.96% |
Total Receivables | -- | -- | -- | 94.10% | -10.03% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -8.36% | 21.78% | 100.83% | -27.13% | -21.40% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -35.42% | -41.26% | -3.38% | -23.56% | 54.00% |
Total Current Assets | -7.08% | -7.48% | -6.05% | -5.32% | -5.55% |
|
|||||
Total Current Assets | -7.08% | -7.48% | -6.05% | -5.32% | -5.55% |
Net Property, Plant & Equipment | -10.75% | 16.00% | 222.68% | -24.47% | -19.66% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | -21.52% | 84.36% | 0.00% | -96.80% |
Total Assets | -7.11% | -7.36% | -5.65% | -5.35% | -6.35% |
|
|||||
Total Accounts Payable | -7.57% | 43.08% | 27.26% | -5.44% | -51.08% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 3.00% | 36.37% | 126.09% | -42.50% | -29.61% |
Total Finance Division Other Current Liabilities | -55.32% | -22.33% | -17.98% | -12.03% | -34.74% |
Total Other Current Liabilities | -55.32% | -22.33% | -17.98% | -12.03% | -34.74% |
Total Current Liabilities | -25.29% | 7.98% | -0.18% | -10.85% | -40.82% |
|
|||||
Total Current Liabilities | -25.29% | 7.98% | -0.18% | -10.85% | -40.82% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -29.33% | 7.18% | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -25.48% | 7.94% | 4.84% | -10.85% | -40.82% |
|
|||||
Common Stock & APIC | 0.20% | 0.41% | 0.35% | 0.35% | 0.32% |
Retained Earnings | -6.60% | -11.00% | -9.85% | -9.42% | -6.73% |
Treasury Stock & Other | 46.98% | 12.65% | 19.31% | 14.62% | -24.82% |
Total Common Equity | -5.90% | -8.21% | -6.18% | -5.06% | -3.36% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -5.90% | -8.21% | -6.18% | -5.06% | -3.36% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -5.90% | -8.21% | -6.18% | -5.06% | -3.36% |
|